Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 5:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 276 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Blood Specimen Collection Clear all

Conditions: IV Catheter-Related Infection or Complication, Vascular Access Complication, Peripheral Venous Access
Interventions: Extended dwell catheters; Device
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
Interventions: Biopsy, Biospecimen Collection, Laboratory Biomarker Analysis, Questionnaire Administration; Procedure · Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chaperonin-Containing TCP-1, Circulating Tumor Cells, CCT, CTC
Interventions: Not listed
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Sample Collection
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 3 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2003
U.S. locations: 2
States / cities: Bethesda, Maryland • Kirkland, Washington

Conditions: Sickle Cell
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lung Carcinoma, Lung Neoplasm, Malignant Lung Neoplasm
Interventions: cytology specimen collection procedure; Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2022
U.S. locations: 19
States / cities: Lewes, Delaware • Newark, Delaware • Elkton, Maryland + 14 more

Conditions: Colorectal Cancer
Interventions: Not listed
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 40 Years and older
Enrollment: 5,131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 40
States / cities: Tempe, Arizona • Chula Vista, California • Huntington Beach, California + 36 more

Conditions: Hemoglobin Mutations, Erythrocyte Variants
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV, Kaposi's Sarcoma, Lymphomas, Multicentric Castleman's Disease, Primary Effusion Lymphoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 1,029 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Melanoma
Interventions: Blood Sample, Tumor Sample; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy
Interventions: Blood Sample Collection; Other
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 1,718 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 31
States / cities: Birmingham, Alabama • Peoria, Arizona • Springdale, Arkansas + 26 more

Conditions: Septicemia
Interventions: Initial Specimen Diversion Device (ISDD), Lab standard practice (LSP), Peripheral Intravenous Catheters (PIVC); Device · Procedure
Lead sponsor: Magnolia Medical Technologies, Inc.; Industry
Eligibility: 19 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COVID-19
Interventions: Not listed
Lead sponsor: DxTerity Diagnostics; Industry
Eligibility: 13 Years and older
Enrollment: 662 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Compton, California

Conditions: Healthy Volunteers
Interventions: Not listed
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 10,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2003
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Lymphoma
Interventions: Ofatumumab, Ifosfamide, Etoposide, Mesna, G-CSF, Stem Cell Collection; Drug · Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Muscular Dystrophies
Interventions: EDG-5506; Drug
Lead sponsor: Edgewise Therapeutics, Inc.; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Hypogonadism, Male
Interventions: Testosterone Undecanoate; Drug
Lead sponsor: Clarus Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Northbrook, Illinois

Conditions: Pregnancy Following IVF With PGS/PGD
Interventions: Blood draw; Procedure
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Anesthesia
Interventions: Tetracaine HCl 3% and Oxymetazoline HCl 0.05%; Drug
Lead sponsor: St. Renatus, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: SARS-COV2 Virus
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 11,363 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Birmingham, Alabama • Bethesda, Maryland • Pittsburgh, Pennsylvania

Conditions: Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection, Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types
Interventions: Not listed
Lead sponsor: TScan Therapeutics, Inc.; Industry
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: New Orleans, Louisiana • Morristown, New Jersey

Conditions: Vascular And Immunologic Diseases, Healthy Volunteers
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2032
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HPV Infection, HIV Infections, HPV-Related Malignancy
Interventions: Mail-based Saliva Sample Kit, Study-related Surveys; Diagnostic Test · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 35 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Primary or Metastatic Central Nervous System (CNS) Tumor
Interventions: Not listed
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 1,128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2009
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Blood Sampling Functionality of Extended Dwell Catheters

Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers

Liquid Biopsy Collection Study

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

Stem Cell Collection for Adult Volunteers

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Sample Collection From Melanoma Patients

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters

COVID-19 Immunity Assessment

Cytapheresis of Volunteer Donors

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing

Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)

SARS-COV2 Pandemic Serosurvey and Blood Sampling

Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes

Controls and Healthy Vasculature Initiative

Feasibility of HPV Testing With Mail-delivered Sample Collection Kits

Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors